FDA approves Exforge HCT® - the only high blood pressure treatment to combine th by Financial News

The US Food and Drug Administration (FDA) has approved Exforge HCT, the only single pill to combine the three most prescribed high blood pressure treatments in their classes in the US[3]: the calcium channel blocker amlodipine, the angiotensin receptor blocker valsartan, and the diuretic hydrochlorothiazide.

(1888PressRelease) May 04, 2009 - Exforge HCT is an important new option for patients who have tried taking dual combinations of these classes of blood pressure medications without success.

"The majority of people with hypertension will require more than one medication to control their blood pressure and it's not uncommon for patients with severe hypertension and/or patients requiring stricter blood pressure control to need three or more medications," said David A. Calhoun, MD, Professor of Medicine, Vascular Biology and Hypertension Program, University of Alabama at Birmingham. "With a triple combination option, appropriate patients may experience a simpler routine of a convenient, once-daily pill to help them control their high blood pressure."

Exforge HCT provides proven efficacy in patients with moderate to severe hypertension (MSDBP 100 mmHg and

###

FDA approves Exforge HCT® - the only high blood pressure treatment to combine three medications in a single pill